Capotosto Lidia, Nguyen Bich Lien, Ciardi Maria Rosaria, Mastroianni Claudio, Vitarelli Antonio
Department of Medicine, Cardiology, Sapienza University, Rome, Italy.
Department of Medicine, Infectious Diseases, Sapienza University, Rome, Italy.
Echocardiography. 2020 Sep;37(9):1454-1464. doi: 10.1111/echo.14834. Epub 2020 Sep 4.
Although clinical manifestations of coronavirus disease of 2019 (COVID-19) mainly consist of respiratory symptoms, a severe cardiovascular damage may occur. Moreover, previous studies reported a correlation of cardiovascular metabolic diseases with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and actually, many COVID-19 patients show comorbidities (systemic hypertension, cardio-cerebrovascular disease, and diabetes) and have a raised risk of death. The purpose of this review is to focus the cardiovascular effects of 2019-nCoV on the base of the most recent specific literature and previous learnings from SARS and MERS and analyze the potential role of echocardiography during the current critical period and short- and long-term follow-up.
尽管2019冠状病毒病（COVID-19）的临床表现主要为呼吸道症状，但可能会发生严重的心血管损害。此外，先前的研究报道了心血管代谢疾病与严重急性呼吸综合征（SARS）和中东呼吸综合征（MERS）之间的相关性，实际上，许多COVID-19患者存在合并症（系统性高血压、心脑血管疾病和糖尿病），且死亡风险增加。本综述的目的是基于最新的具体文献以及先前从SARS和MERS中获得的经验，聚焦2019新型冠状病毒（2019-nCoV）对心血管的影响，并分析超声心动图在当前关键时期以及短期和长期随访中的潜在作用。
